Anna Nowak, MD
Faculty of Health and Medical Sciences University of Western Australia · Sir Charles Gairdner Hospital - Nedlands
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Anna Nowak, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 04:01 UTC. Open this list on ClinicalTrials.gov
- Ph3NCT04334759 · DuRvalumab With chEmotherapy as First Line treAtment in Advanced Pleural MesotheliomaPrECOG, LLC. · completed · Mesothelioma, Pleural Mesothelioma, Malignant Pleural Mesothelioma · study chair
- Ph3NCT00626990 · Phase III Trial of Anaplastic Glioma Without 1p/19q Loss of Heterozygosity (LOH)European Organisation for Research and Treatment of Cancer - EORTC · active not recruiting · Brain and Central Nervous System Tumors · study chair
Grants
NIH projects from RePORTER, fetched 2026-11-12 04:01 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.